Salirasib
Chemical Name: 2-[[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl]thio]benzoic acid
Purity: ≥98%
Biological Activity
Salirasib is an inhibitor of active Ras proteins. Displaces active Ras from the plasma membrane; impairs downstream signaling and inhibits proliferation of endometrial carcinoma cells. Also facilitates Ras degradation. Shown to induce autophagy in several human cancer cell lines.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Ras inhibition enhances autophagy, which partially protects cells from death.
Schmukler et al.
Oncotarget, 2013;4:142 -
Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib.
Faigenbaum et al.
Oncotarget, 2013;4:316 -
Dislodgement and accelerated degradation of Ras.
Haklai et al.
Biochemistry, 1998;37:1306
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for Salirasib
The citations listed below are publications that use Tocris products. Selected citations for Salirasib include:
2 Citations: Showing 1 - 2
-
Is Ras a potential target in treatment against cutaneous squamous cell carcinoma?.
Authors: Li Et al.
J Cancer 2018;9:3373
-
A systems-biological study on the identification of safe and effective molecular targets for the reduction of ultraviolet B-induced skin pigmentation.
Authors: Lee Et al.
J Virol 2015;5:10305
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for Salirasib
There are currently no reviews for this product. Be the first to review Salirasib and earn rewards!
Have you used Salirasib?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
